1,795 research outputs found
Diego de Siloe, aprendiz destacado en el taller de Felipe Bigarny
El hallazgo de un documento conservado en el Archivo de la Real Chancillería de Valladolid, permite constatar la presencia del joven Diego de Siloe en el taller de Felipe de Bigarny en los años precedentes a su viaje a Italia, donde trabajó con Bartolomé Ordóñez. La reclamación de Diego de Siloe de una cantidad que le adeudaba Felipe de Bigarny, dio lugar a un pleito cuyas sucesivas sentencias confirman la participación de Siloe en los trabajos de la sillería de la catedral de Burgos, al tiempo que permiten deducir algunos datos inéditos en la biografía de ambos artistas
Low-Cost Three-Quadrant Single Solar Cell I-V Tracer
An I-V curve measurement technique is one of the most important techniques available
for characterising photovoltaic cells. Measuring an accurate I-V curve at the single-cell level is a
challenging task because of the low voltages and high currents implied, requiring the management of
very low impedances. In this paper, the authors propose a low-cost device for I-V curve measurements
of single (or small amounts) of cells in a series based on the charge transfer between two capacitors
of equal capacitance. Our measurement strategy allows us to trace the usual first quadrant curve
(the normal working region of solar cells) as well as the second and fourth quadrants of the I-V
curve, which are quite important for research purposes. A prototype was built to demonstrate the
feasibility and successful measurements of the three-quadrant I-V curve, obtained for more than
20 different cells. To use the device in a laboratory, without depending on the solar irradiation, a
modular platform was 3D-printed, integrating a board with infrared LEDs as irradiating devices, and
housing (to place the solar cell under test). The result is a useful low-cost setup for three-quadrant
I-V curve tracing that works as expected.Proyecto de Investigación PID2020-113533RB-C33 (MCIN
A Power-Line Communication System Governed by Loop Resonance for Photovoltaic Plant Monitoring
Within this paper, a PLC system that takes advantage of the loop resonance of an entire DC-PV string configured as a circular signal path is developed and implemented. Low cost and extremely simple transceivers intended to be installed within each PV module of a string have been designed and successfully tested. In addition, an anti-saturation coil has been conceived to avoid saturation of the core when the entire DC current of the string flows through it. Bi-directional half-duplex communication was successfully executed with up to a 1 MHz carrier frequency (150 kbps bitrate), using a simple ASK modulation scheme. The transmission and reception performance are presented, along with the overall system cost in comparison to the previous literatureThis research was funded by the Universidad dee Valladolid with the predoctoral contracts of 2020 cofunded by Santander Bank. This study was also supported by the Universidad dee Valladolid with ERASMUS+ KA-107. Partial funding for open access charge: Universidad de Málag
A Resonant Ring Topology Approach to Power Line Communication Systems within Photovoltaic Plants
Within this study, single-cable propagation facilitated by PV strings’ wiring characteristics is considered for an adapted design of PLC electronics. We propose to close the communications signal path, resulting in a ring topology where a resonance condition could be implemented. A PLC topology using the resulting circular closed-loop path of a PV series string as its physical communication support is designed and leveraged for practical use. When the path length or the number of transceivers is changed, the resonance properties that come with the circular path as the physical support are affected but are shown to be preserved with the application of automatic adjustable tuning. This automatic tuning guarantees that the resonance improves propagation parameters and reverts the system to its optimal values at the chosen carrier frequency.This study was supported by the Universidad of Valladolid with the predoctoral contracts of 2020 cofunded by Santander Bank. This study was supported by the Universidad of Valladolid with ERASMUS+ KA-107. Partial funding for open access charge: Universidad de Málag
Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial
Background: Acute heart failure patients could benefit from heart rate reduction, as myocardial consumption and oxidative stress are related to tachycardia. Ivabradine could have a clinical role attenuating catecholamine-induced tachycardia. The aim of this study was to evaluate hemodynamic effects of ivabradine in a swine model of acute heart failure.
Methods: Myocardial infarction was induced by 45 min left anterior descending artery balloon occlusion in 18 anesthetized pigs. An infusion of dobutamine and noradrenaline was maintained aiming to preserve adequate hemodynamic support, accompanied by fluid administration to obtain a pulmonary wedged pressure ≥ 18 mmHg. After reperfusion, rhythm and hemodynamic stabilization, the animals were randomized to 0.3 mg/kg ivabradine intravenously (n = 9) or placebo (n = 9). Hemodynamic parameters were observed over a 60 min period.
Results: Ivabradine was associated with a significant reduction in heart rate (88.4 ± 12.0 bpm vs. 122.7 ± 17.3 bpm after 15 min of ivabradine/placebo infusion, p < 0.01) and an increase in stroke volume (68.8 ± 13.7 mL vs. 52.4 ± 11.5 mL after 15 min, p = 0.01). There were no significant differences in systemic or pulmonary arterial pressure, or significant changes in pulmonary capillary pressure. However, after 15 min, cardiac output was significantly reduced with ivabradine (–5.2% vs. +15.0% variation in ivabradine/placebo group, p = 0.03), and central venous pressure increased (+4.2% vs. –19.7% variation, p < 0.01).
Conclusions: Ivabradine reduces heart rate and increases stroke volume without modifying systemic or left filling pressures in a swine model of acute heart failure. However, an excessive heart rate reduction could lead to a decrease in cardiac output and an increase in right filling pressures. Future studies with specific heart rate targets are needed
Ivabradine in acute heart failure: Effects on heart rate and hemodynamic parameters in a randomized and controlled swine trial.
Background: Acute heart failure patients could benefit from heart rate reduction, as
myocardial consumption and oxidative stress are related to tachycardia. Ivabradine
could have a clinical role attenuating catecholamine-induced tachycardia. The aim of
this study was to evaluate hemodynamic effects of ivabradine in a swine model of acute
heart failure.
Methods: Myocardial infarction was induced by 45 min left anterior descending artery
balloon occlusion in 18 anesthetized pigs. An infusion of dobutamine and noradrenaline
was maintained aiming to preserve adequate hemodynamic support, accompanied by fluid administration to obtain a pulmonary wedged pressure ≥ 18 mmHg. After
reperfusion, rhythm and hemodynamic stabilization, the animals were randomized to
0.3 mg/kg ivabradine intravenously (n = 9) or placebo (n = 9). Hemodynamic
parameters were observed over a 60 min period.
Results: Ivabradine was associated with a significant reduction in heart rate (88.4 ±
12.0 bpm vs. 122.7 ± 17.3 bpm after 15 min of ivabradine/placebo infusion, p < 0.01)
and an increase in stroke volume (68.8 ± 13.7 mL vs. 52.4 ± 11.5 mL after 15 min, p =
0.01). There were no significant differences in systemic or pulmonary arterial pressure,
or significant changes in pulmonary capillary pressure. However, after 15 min, cardiac
output was significantly reduced with ivabradine (–5.2% vs. +15.0% variation in
ivabradine/placebo group, p = 0.03), and central venous pressure increased (+4.2% vs. –
19.7% variation, p < 0.01).
Conclusions: Ivabradine reduces heart rate and increases stroke volume without
modifying systemic or left filling pressures in a swine model of acute heart failure.
However, an excessive heart rate reduction could lead to a decrease in cardiac output
and an increase in right filling pressures. Future studies with specific heart rate targets
are needed.pre-print2533 K
Proteomic analysis of low-grade, early-stage endometrial carcinoma reveals new dysregulated pathways associated with cell death and cell signaling
Low-grade, early-stage endometrial carcinoma (EC) is the most frequent malignant tumor of the uterine corpus. However, the molecular alterations that underlie these tumors are far from being fully understood. The purpose of this study is to describe dysregulated molecular pathways from EC patients. Sixteen samples of tumor tissue and paired healthy controls were collected and both were subjected to mass spectrometry (MS)/MS proteomic analysis. Gene ontology and pathway analysis was performed to discover dysregulated pathways and/or proteins using different databases and bioinformatic tools. Dysregulated pathways were cross-validated in an independent external cohort. Cell signaling, immune response, and cell death-associated pathways were robustly identified. The SLIT/ROBO signaling pathway demonstrated dysregulation at the proteomic and transcriptomic level. Necroptosis and ferroptosis were cell death-associated processes aberrantly regulated, in addition to apoptosis. Immune response-associated pathways showed a dominance of innate immune responses. Tumor immune infiltrates measured by immunofluorescence demonstrated diverse lymphoid and myeloid populations. Our results suggest a role of SLIT/ROBO, necroptosis, and ferroptosis, as well as a prominent role of innate immune response in low-grade, early-stage EC. These results could guide future research in this group of tumorsThis research was funded by the Instituto de Salud Carlos III (ISCIII) (PI17/01723), cofinanced
by the European Development Regional Fund “A way to achieve Europe” (FEDER
Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
[EN]There is evidence of continuous bidirectional cross-talk between malignant cells and bone
marrow-derived mesenchymal stromal cells (BM-MSC), which favors the emergence and
progression of myeloproliferative neoplastic (MPN) diseases. In the current work we have
compared the function and gene expression profile of BM-MSC from healthy donors (HDMSC)
and patients with MPN (JAK2V617F), showing no differences in the morphology, proliferation
and differentiation capacity between both groups. However, BM-MSC from MPN
expressed higher mean fluorescence intensity (MIF) of CD73, CD44 and CD90, whereas
CD105 was lower when compared to controls. Gene expression profile of BM-MSC showed
a total of 169 genes that were differentially expressed in BM-MSC from MPN patients compared
to HD-MSC. In addition, we studied the ability of BM-MSC to support the growth and
survival of hematopoietic stem/progenitor cells (HSPC), showing a significant increase in
the number of CFU-GM colonies when MPN-HSPC were co-cultured with MPN-MSC.
Furthermore, MPN-MSC showed alteration in the expression of genes associated to the
maintenance of hematopoiesis, with an overexpression of SPP1 and NF-kB, and a downregulation
of ANGPT1 and THPO. Our results suggest that BM-MSC from JAK2+ patients
differ from their normal counterparts and favor the maintenance of malignant clonal hematopoietic
cell
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy:Study protocol of a cluster randomized clinical trial (Multi-PAP project)
This study was funded by the Fondo de Investigaciones Sanitarias ISCIII (Grant Numbers PI15/00276, PI15/00572, PI15/00996), REDISSEC (Project Numbers RD12/0001/0012, RD16/0001/0005), and the European Regional Development Fund ("A way to build Europe").Background: Multimorbidity is associated with negative effects both on people's health and on healthcare systems. A key problem linked to multimorbidity is polypharmacy, which in turn is associated with increased risk of partly preventable adverse effects, including mortality. The Ariadne principles describe a model of care based on a thorough assessment of diseases, treatments (and potential interactions), clinical status, context and preferences of patients with multimorbidity, with the aim of prioritizing and sharing realistic treatment goals that guide an individualized management. The aim of this study is to evaluate the effectiveness of a complex intervention that implements the Ariadne principles in a population of young-old patients with multimorbidity and polypharmacy. The intervention seeks to improve the appropriateness of prescribing in primary care (PC), as measured by the medication appropriateness index (MAI) score at 6 and 12months, as compared with usual care. Methods/Design: Design:pragmatic cluster randomized clinical trial. Unit of randomization: family physician (FP). Unit of analysis: patient. Scope: PC health centres in three autonomous communities: Aragon, Madrid, and Andalusia (Spain). Population: patients aged 65-74years with multimorbidity (≥3 chronic diseases) and polypharmacy (≥5 drugs prescribed in ≥3months). Sample size: n=400 (200 per study arm). Intervention: complex intervention based on the implementation of the Ariadne principles with two components: (1) FP training and (2) FP-patient interview. Outcomes: MAI score, health services use, quality of life (Euroqol 5D-5L), pharmacotherapy and adherence to treatment (Morisky-Green, Haynes-Sackett), and clinical and socio-demographic variables. Statistical analysis: primary outcome is the difference in MAI score between T0 and T1 and corresponding 95% confidence interval. Adjustment for confounding factors will be performed by multilevel analysis. All analyses will be carried out in accordance with the intention-to-treat principle. Discussion: It is essential to provide evidence concerning interventions on PC patients with polypharmacy and multimorbidity, conducted in the context of routine clinical practice, and involving young-old patients with significant potential for preventing negative health outcomes. Trial registration: Clinicaltrials.gov, NCT02866799Publisher PDFPeer reviewe
Manual de simulación clínica en especialidades médicas
Manual sobre técnicas y modos de simulación clínica en diversas especialidades médicas.La enseñanza y formación en medicina necesita el uso de la simulación. Existen evidencias de su uso desde hace cientos de años, pero, en los últimos años se ha incrementado y diseminado.
La simulación clínica está validada científicamente en múltiples contextos médicos y de otras áreas profesionales de la salud. Y es considerada de gran importancia como proceso de entrenamiento y de mejora de las competencias y adquisición de habilidades médicas en campos que incluye desde la historia clínica, comunicación con el paciente, exploración, diagnóstico terapéutica médica-farmacológica y quirúrgica y seguridad al tratar al paciente.
Hoy en día, para muchas técnicas y situaciones clínicas es inaceptable llegar junto a los pacientes sin un dominio adquirido en simulación. La simulación puede ocurrir sin el uso de recursos adicionales, solo las personas, o utilizando pocos o muchos recursos de baja hasta alta tecnología y se puede adaptar a los recursos disponibles, abarcando todas las áreas de conocimiento, y dentro de ellas competencias técnicas o actitudes, solas o en conjunto.
El uso racional y basado en evidencia de la simulación es de la mayor importancia por la necesidad de una mayor efectividad y eficiencia en la transformación de los profesionales de la salud para que puedan mejorar su capacidad de atender a los pacientes.
La simulación es también una buena herramienta de evaluación de competencias y habilidades en Medicina y otras disciplinas de las Ciencias de la Salud
Este manual incluye técnicas y modos de simulación clínica en diversas especialidades médicas, útiles, para quien busque un manual práctico y actualizado.Cátedra de Mecenazgo de la Universidad de Málaga. Cátedra de Terapias Avanzadas en Patología Cardiovascular
Cátedra de Mecenazgo de la Universidad de Málaga. Cátedra de Investigación Biomédica Quirón Salu
- …